- Name: Su Xiao-Dong
- Title: Associate Professor and advisor of master’s degree student
- Email:
- Phone:
Dr. Su has been working in the department of thoracic surgery, SYSUCC since July 1993 after graduated from Sun Yet Sen University of Medical Science (now Sun Yet Sen University). His expertise includes: Diagnosis and staging of thoracic tumor including carcinoma of lung, esophagus and mediastium; Surgical treatment of carcinoma of lung, esophagus and mediastium; Management of postoperative complications; Multidisciplinary management of cancer of lung and esophagus.
1987 –1993 Sun Yet-Sen University of Medical Science ( now Sun Yet-Sen University ) Bachelor of Medicine;
1999 – 2001 University Of New South Wales, Australia, Master of Community Medicine;
2003 – 2006 Sun Yet-Sen University, Ph.D of Oncology/ Surgical Oncology
1. Mediastinal lymph node dissection affects survival in patients with stage I non small cell lung cancer. The Thoracic and Cardiovascular Surgeon 2008,56(4):226
2. (co-author)Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2. Cancer Res 2008;68(19):7905–14
3. Impact of the number of resected and involved lymph nodes on the outcome in patients with stage II non small cell lung cancer. Chin J Oncol 2010:;32(6):436
4. Study on histological heterogeneity of non small cell lung cancer. China Cancer 2008;17(12):36
5. Impact of visceral pleural invasion on the prognosis of stage Ib non small cell lung cancer. Chin J Oncol. 2008,30(5):368.
6. Correlations of novel histological classification of 82 thymoma patients to their clinical characteristic and prognosis. Chin J Cancer. 2005,24(11):1363 .
7. Combined surgical treatment for limited small cell lung cancer :clinical analysis of 51 cases. Chin J Cancer 2003;10:1099-1101。
8. An analysis of smoking status in the community in Guangzhou. China Cancer 2005,14(12):776.
9. . Prediagnostic smoking and postoperative survival in lymph node-negative esophagus squamous cell carcinoma patients Cancer Sci 2012; 103: 1985–1988
10. Surgical approach and outcomes for treatment of pulmonary metastases Ann Thorac Med 2013;8:160-4
11. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis 2014;6(7):949.
The second author:
12. Clinical analysis of primary lymphoepithelioma-like carcinoma of the lung. Chin J Oncol 2008;30(1):72.
13. Emodin azide methyl anthraquionoe derivative triggers mitochondrial-dependent cell apoptosis involving in caspase-8-mediated Bid cleavage. Molecular Cancer Therapy 2008,7(6):1688
14. Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy. Chin J Cancer. 2008;27(2):113.
15. Clinical analysis of 22 cases of esophageal adenosquamous carcinoma. Chin J Oncol 2009;31(4):302.
16. Survival analysis of 220 patients with completely resected stage II non small cell lung cancer. Chin J Cancer 2010;29(5):538.
Last Updated on: August 2014 by International Office, Sun Yat-sen University Cancer Center